Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program
about
Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing program.Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis.Sensitivity of neuroblastoma to the novel kinase inhibitor cabozantinib is mediated by ERK inhibition.Identifying novel therapeutic agents using xenograft models of pediatric cancer.A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology.Temozolomide combined with irinotecan regresses a cisplatinum-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) precision-oncology mouse model.
P2860
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program
@ast
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program
@en
type
label
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program
@ast
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program
@en
prefLabel
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program
@ast
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program
@en
P2093
P2860
P50
P356
P1476
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program
@en
P2093
Christopher L Morton
E Anders Kolb
Hernan Carol
Jianrong Wu
John M Maris
Peter J Houghton
Raushan T Kurmasheva
Stephen T Keir
P2860
P304
P356
10.1002/PBC.24368
P577
2013-01-17T00:00:00Z